Drugs / Jing Si herbal tea
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT06584786 | Jan 2022 → Dec 2024 overdue | lower respiratory tract disorder | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation | Recruiting | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT06901557 | Jan → Dec 2024 | bronchiectasis | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation | Completed | No outcome recorded |
| — | NCT04967755 | Jun → Aug 2021 | COVID-19 | Yao-Kuang Wu | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Jing Si herbal tea | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06584786 ↗ |
| Known as | JSHT | “Jing Si herbal tea (JSHT) is a herbal blend formulated to regulate the immune system and treat inflammatory respiratory conditions.” NCT06584786 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Chinese herbal medicine Jing si herbal tea” NCT04967755 ↗ |